(Q43087780)

13 November 2017

Altered intestinal microbiota in irritable bowel syndrome (English)

1 reference

13 November 2017

Lee KJ

1

1 reference

PubMed ID

20414959

13 November 2017

Tack J

series ordinal

2

1 reference

13 November 2017

1 May 2010

1 reference

Neurogastroenterology and Motility

13 November 2017

1 reference

13 November 2017

22

1 reference

13 November 2017

493-498

1 reference

13 November 2017

5

1 reference

Irritable bowel syndrome: a little understood organic bowel disease?

13 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Alterations in intestinal microbial flora and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

A new rat model links two contemporary theories in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Intestinal microecology and quality of life in irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Alterations in the intestinal microbiota and functional bowel symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

PCR DGGE and RT-PCR DGGE show diversity and short-term temporal stability in the Clostridium coccoides-Eubacterium rectale group in the human intestinal microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Altered gut flora and environment in patients with severe SIRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Effect of organic acids on inhibition of Escherichia coli O157:H7 colonization in gnotobiotic mice associated with infant intestinal microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

Lactobacillus farciminis treatment attenuates stress-induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2010.01482.X

10.1111/J.1365-2982.2010.01482.X

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference

PubMed ID

20414959